DISCOUNT-ZERTIFIKAT - SARTORIUS VZ Share Price

Certificat

DE000DW8PTF8

Market Closed - Deutsche Boerse AG 01:04:11 29/06/2024 am IST
180.2 EUR +0.57% Intraday chart for DISCOUNT-ZERTIFIKAT - SARTORIUS VZ
Current month-2.67%
1 month-3.19%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 180.2 +0.57%
27/24/27 179.2 -0.79%
26/24/26 180.6 +0.43%
25/24/25 179.8 -0.58%
24/24/24 180.9 +1.33%

Delayed Quote Deutsche Boerse AG

Last update June 29, 2024 at 01:04 am IST

More quotes

Static data

Product typeCertificados de Descuento
Buy / SellCALL
Underlying SARTORIUS AG
Issuer DZ BANK
WKN DW8PTF
ISINDE000DW8PTF8
Date issued 27/12/2022
Maturity 20/12/2024 (174 Days)
Parity 1 : 1
Emission price 187.8
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 192.4
Lowest since issue 164.5
Spread 0.48
Spread %0.27%

Company Profile

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Sector
-
More about the company

Ratings for Sartorius AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Sartorius AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
219 EUR
Average target price
314.9 EUR
Spread / Average Target
+43.78%
Consensus